Samath Jamie - Oct 22, 2021 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
SVP of Finance
Signature
By: Donna Spinola For: Jamie Samath
Stock symbol
ISRG
Transactions as of
Oct 22, 2021
Transactions value $
-$248,397
Form type
4
Date filed
10/26/2021, 05:09 PM
Previous filing
Aug 27, 2021
Next filing
Feb 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $37.8K +156 +20.47% $242.34 918 Oct 22, 2021 Direct F1, F2
transaction ISRG Common Stock Sale -$53K -156 -16.99% $339.71 762 Oct 22, 2021 Direct F1, F2, F3
transaction ISRG Common Stock Options Exercise $27.8K +156 +20.47% $177.99 918 Oct 22, 2021 Direct F1, F2
transaction ISRG Common Stock Sale -$53K -156 -16.99% $339.66 762 Oct 22, 2021 Direct F1, F2, F4
transaction ISRG Common Stock Options Exercise $45.5K +273 +35.83% $166.62 1.04K Oct 22, 2021 Direct F1, F2
transaction ISRG Common Stock Sale -$92.7K -273 -26.38% $339.66 762 Oct 22, 2021 Direct F1, F2, F4
transaction ISRG Common Stock Options Exercise $49.9K +273 +35.83% $182.83 1.04K Oct 22, 2021 Direct F1, F2
transaction ISRG Common Stock Sale -$92.7K -273 -26.38% $339.66 762 Oct 22, 2021 Direct F1, F2, F4
transaction ISRG Common Stock Options Exercise $55.9K +321 +42.13% $174.26 1.08K Oct 22, 2021 Direct F1, F2
transaction ISRG Common Stock Sale -$109K -321 -29.64% $339.66 762 Oct 22, 2021 Direct F1, F2, F4
transaction ISRG Common Stock Options Exercise $45.2K +324 +42.52% $139.52 1.09K Oct 22, 2021 Direct F1, F2
transaction ISRG Common Stock Sale -$110K -324 -29.83% $339.66 762 Oct 22, 2021 Direct F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -324 -42.86% $0.00 432 Oct 22, 2021 Common Stock 324 $139.52 Direct F1, F2, F5
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -273 -15.85% $0.00 1.45K Oct 22, 2021 Common Stock 273 $166.62 Direct F1, F2, F6
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -321 -42.63% $0.00 432 Oct 22, 2021 Common Stock 321 $174.26 Direct F1, F2, F6
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -156 -9.3% $0.00 1.52K Oct 22, 2021 Common Stock 156 $177.99 Direct F1, F2, F5
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -273 -15.85% $0.00 1.45K Oct 22, 2021 Common Stock 273 $182.83 Direct F1, F2, F7
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -156 -9.34% $0.00 1.52K Oct 22, 2021 Common Stock 156 $242.34 Direct F1, F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 8, 2021.
F2 On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.64 to $341.03 as follows: 20 shares sold at $338.64 to $338.99; 106 shares sold at $339.06 to $339.98; 30 shares sold at $340.04 to $341.03. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.47 to $341.34 as follows:179 shares sold at $338.47 to $338.99; 866 shares sold at $339 to $339.99; 280 shares sold at $340.09 to $340.82; 22 shares sold at $341 to $341.34. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F6 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48th one month after the date of grant and 1/48th monthly thereafter.
F7 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.